Davies N M, Spaven J R, Chambers C R
Tom Baker Cancer Centre, Calgary, Alberta.
Can J Hosp Pharm. 1992 Jun;45(3):107-11.
Clinical pharmacy activities that affect patient outcome are a high priority in pharmacy practice. A relatively simple method of documentation for analysis of these clinical pharmacy activities in an out-patient oncology setting is described. Policies and procedures for clinical pharmacy activities were developed and formalized in an effort to standardize pharmaceutical care in the cancer facility. Consultations or drug information questions originating outside the pharmacy, as well as interventions initiated by a pharmacist were all documented on a comprehensive activity form on a daily basis by each pharmacist. All medication counseling sessions by a pharmacist were also recorded. During a 12 month study period, a total of 1828 activities were recorded. Of these, 343 (18.8%) were pharmacist-initiated interventions to drug therapy. Recommendations were accepted by physicians in 293 (85.4%) of these interventions. In 125 (36.4%) cases, potentially serious negative patient outcomes were avoided by this clinical pharmacy activity.
影响患者治疗结果的临床药学活动是药学实践中的重中之重。本文描述了一种相对简单的记录方法，用于分析门诊肿瘤环境中的这些临床药学活动。制定并规范了临床药学活动的政策和程序，以努力使癌症治疗机构的药学服务标准化。药房外部发起的咨询或药物信息问题，以及药剂师发起的干预措施，均由每位药剂师每天记录在一份综合活动表格上。药剂师进行的所有用药咨询会议也都有记录。在为期12个月的研究期间，共记录了1828项活动。其中，343项（18.8%）是药剂师发起的药物治疗干预措施。在这些干预措施中，293项（85.4%）的建议被医生接受。在125例（36.4%）病例中，通过这项临床药学活动避免了潜在的严重负面患者治疗结果。
